Ketocare

Quick links to important sections

Ketocare

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ketocare

Property Description
Active Ingredient Ketoconazole
Forms Cream, Shampoo, Tablet
Pharmacological Class Azole Antifungal Drug
General Purpose Controlling Fungal Infections
Origin Synthetic Compound

What Type of Medicine is Ketocare?

Ketocare is defined as a pharmaceutical preparation whose active pharmaceutical ingredient (API) is the substance Ketoconazole, classifying it as a synthetic Azole Antifungal drug. This medicine belongs to the broader category of Antimycotic agents, a class that is clinically recognized for its effectiveness against fungal pathogens. The International Nonproprietary Name (INN) Ketoconazole identifies the compound as a synthetic nitrogen-containing heterocyclic compound of the Imidazole subclass. This pharmacological classification verifies that Ketocare is chemically engineered for targeted anti-fungal action, serving as a foundational therapeutic option for addressing the underlying cause of mycotic conditions.

Ketocare: Active Ingredient and Available Forms

The formulation of Ketocare is a single-ingredient product, containing solely the API Ketoconazole, yet it is available in multiple distinct dosage forms. Ketoconazole is prepared as various topical preparations, such as a cream or a shampoo, and also as an oral medication in the form of a tablet. This diverse presentation dictates the intended route of administration, which may be topical for superficial issues or oral for conditions requiring a systemic approach. The different forms utilize varying bases or vehicles, such as an emollient cream base or excipients, to ensure effective delivery of the active ingredient to the target area, accommodating different patient needs, such as a shampoo for treating the scalp.

How Does Ketocare Fundamentally Control Fungal Infections?

The fundamental physiological action of Ketocare involves a targeted biochemical process known as Ergosterol Synthesis Inhibition. The Ketoconazole component selectively blocks a critical enzyme necessary for the fungus to synthesize ergosterol, a molecule essential for maintaining the fungal cell membrane. By damaging the membrane via Cell Membrane Disruption, Ketocare is able to exert both a fungistatic effect, stopping the growth of the organism, and a fungicidal effect, which leads to the elimination of the cell. This fundamental action is the biological reason the preparation is utilized as an antimycotic agent.

Regulatory References

  1. Ketoconazole Topical Drug Information (MedlinePlus)

What side effects are possible with Ketocare?

The officially documented safety profile for Ketocare (Ketoconazole) varies significantly depending on the route of administration, distinguishing between systemic (oral tablet) and local (topical cream/shampoo) exposure.

Oral (Tablet) Systemic Safety Profile

The most significant safety documentation for the oral tablet concerns serious adverse reactions related to the Hepatobiliary and Cardiac systems. Officially documented serious reactions include severe Hepatotoxicity (liver injury, potentially fatal or requiring transplantation) and risks of QT Prolongation, which can lead to life-threatening ventricular dysrhythmias. Furthermore, cases of Adrenal Insufficiency and Anaphylaxis have been reported.

Commonly reported non-serious adverse reactions are classified primarily under Gastrointestinal Disorders, such as nausea, vomiting, abdominal pain, and headache. The systemic safety profile is not considered established for use in children younger than 2 years of age. Regulatory labeling also notes that serious liver effects have been reported with both short and long treatment durations.

Topical (Cream, Shampoo) Local Safety Profile

The safety profile for the cream and shampoo is largely confined to Skin and Subcutaneous Tissue Disorders at the application site due to minimal systemic absorption. Common adverse reactions include application site pruritus (itching), skin burning sensation, and erythema (redness). Uncommon effects may include folliculitis or dry skin. Severe systemic hypersensitivity reactions, such as anaphylaxis, have been reported in post-marketing surveillance, though rarely. Topical preparations are explicitly contraindicated in individuals with known hypersensitivity to the drug or excipients and must not be used in the eyes.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Ketocare tablets involves systemic exposure risks that are officially documented by regulatory authorities. The most critical manifestations include signs of acute liver injury, such as jaundice, dark urine, or severe nausea and fatigue. Severe overdose may also present with life-threatening cardiovascular events, including irregular heartbeat or fainting due to the potential for QT prolongation and subsequent ventricular dysrhythmias.

Additionally, a critical risk is the development of Adrenal Insufficiency (Hypocortisolism), which can manifest as profound weakness and hypotension. The official regulatory guidance mandates seeking immediate medical attention upon suspicion of an overdose or the appearance of any severe symptoms. Contact emergency services immediately if the affected individual has collapsed, had a seizure, is experiencing trouble breathing, or exhibits a highly irregular heart rhythm.

In the event of an overdose, no specific antidote is known. Management procedures described in official labeling focus on supportive and symptomatic measures, which may involve gastric lavage or activated charcoal if ingestion was recent. Treatment requires close hospital monitoring of vital signs, electrolyte balance, and liver function tests over a period of days, and may include the administration of Hydrocortisone if Adrenal Insufficiency is diagnosed.

Therapeutic Uses of Ketocare

What Ketocare Treats: Main Uses and Benefits

Ketocare is applied across domains where additional symptomatic support is needed, often involving fungal activity. This medication is commonly used across conditions presenting with localized discomfort and inflammatory or irritative states. This may assist with managing conditions such as ringworm (Tinea corporis), athlete's foot (Tinea pedis), jock itch (Tinea cruris), cutaneous candidiasis, and chronic issues like seborrheic dermatitis.

It supports the management of associated symptom clusters. This is relevant for easing challenging symptoms like scaling, flaking, and pruritus (itching) of the scalp. In clinical settings that involve acute or unstable symptom patterns, it is also considered relevant for supportive management in serious systemic fungal diseases like Blastomycosis and Histoplasmosis. The use of this medication may provide supportive relief that helps ease the overall symptom burden and contributes to improved day-to-day comfort.


Quick Fact: Therapeutic Domains

This medication is relevant for managing symptoms that create noticeable functional strain, particularly the scaling and pruritus associated with dermatological mycoses and chronic fungal-linked conditions like seborrheic dermatitis.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

The eligibility profile for Ketocare (Ketoconazole) is rigidly determined by its dosage form, with the oral tablet carrying severe restrictions due to systemic risks. Official regulatory documents establish specific population exclusions and conditional uses, defining who is allowed to receive the medicine.

Population Status Oral Tablet (Systemic) Topical Forms (Cream/Shampoo)
Contraindicated Acute or chronic liver disease, pre-treatment elevated liver enzymes, QTc prolongation, and co-administration with specific medications (e.g., simvastatin, quinidine). Known hypersensitivity to the active ingredient or any component of the formulation.
Restricted Use Permitted only for specific life-threatening systemic mycoses (e.g., blastomycosis) when alternative therapies have failed or are not tolerated. No specific systemic restrictions apply.
Age Eligibility Safety and efficacy not established in children under 2 years of age. Safety and effectiveness not established in children (generally under 12 years).
Reproductive Status Contraindicated during pregnancy and breastfeeding by some regulators; use must be strictly weighed against risk. Use with caution; generally not detected in plasma, but should only be used if benefit justifies risk.

These official statements define who is eligible, with the oral formulation being designated exclusively as a last-resort treatment for a highly restricted patient population, while the topical products are less constrained in their use.

What should I know about interactions with other medicines?

Ketocare (ketoconazole) oral tablets can interact with a large number of other medications, potentially leading to serious or life-threatening adverse effects. These interactions are primarily due to ketoconazole's effect as a potent inhibitor of the enzyme CYP3A4 in the liver, which is responsible for metabolizing many other drugs.


Medications with Major Contraindications

The following are examples of drug classes and specific medicines that must not be taken with Ketocare due to the risk of serious side effects, including QT prolongation (a potentially fatal heart rhythm abnormality) or significantly increased drug exposure:

Drug Class / Type Examples of Affected Drugs
Antiarrhythmics Dofetilide, Quinidine, Dronedarone
Statins (Cholesterol) Lovastatin, Simvastatin
Erectile Dysfunction Sildenafil (certain doses), Tadalafil
Benzodiazepines Alprazolam, Midazolam, Triazolam (oral)
Opioid Pain Relievers Methadone, Fentanyl, Oxycodone
Ergot Derivatives (Migraine) Ergotamine, Dihydroergotamine

Other Significant Interactions

  • Stomach Acid Reducers: Medicines like antacids, H2 blockers (e.g., famotidine), and Proton Pump Inhibitors (e.g., omeprazole) can reduce stomach acidity, which is required for proper absorption of Ketocare. Dosage timing or using an acidic beverage may be necessary.
  • CYP3A4 Inducers: Drugs such as rifampin, isoniazid, and phenytoin can decrease Ketocare’s blood levels, reducing its effectiveness.
  • Alcohol: Consumption of alcoholic beverages is contraindicated with Ketocare tablets due to an increased risk of severe liver problems and unpleasant reactions like flushing or nausea.

Always provide a complete list of all medications, over-the-counter products, and herbal supplements to your healthcare provider for a thorough review before starting or stopping any treatment with Ketocare.

Mechanism of Action

Targeting Fungal Ergosterol Biosynthesis

The core mechanism involves the selective inhibition of the fungal enzyme Lanosterol 14-alpha-demethylase (CYP51), an essential component of the ergosterol synthesis pathway. By suppressing this specific enzymatic step, the drug prevents the necessary production of ergosterol, the primary sterol responsible for structuring the fungal cell membrane.

Cellular Disruption and Loss of Viability

The resulting depletion of ergosterol, alongside the accumulation of toxic sterol intermediates, initiates a cascade of cellular dysfunction. This compromise in the cell membrane's barrier function leads to the leakage of intracellular components and disrupts membrane-bound enzyme activity. This mechanism results in the inhibition of fungal cell reproduction (fungistatic) and, at sufficient concentrations, causes induced cell lysis (fungicidal).

Scope and Contextual Limitations

While primarily affecting fungal cells, the mechanism of action, when the drug is absorbed systemically in high concentrations, extends to influencing specific mammalian Cytochrome P450 enzymes involved in host steroid hormone synthesis. Furthermore, the mechanism is biologically constrained in scenarios involving fungal resistance, such as active efflux pumps, which limit the drug concentration available at the cellular target site.

Dosage and Administration Information

The use of Ketocare is governed by the specific routes of administration and distinct formulations authorized by regulatory agencies. The medicine is available as an oral tablet for systemic use and as topical preparations (cream, shampoo, gel, or foam), which are strictly designated for external use only.

For systemic administration, the standard adult starting dose is 200 mg taken once daily, with the option to increase the dose up to 400 mg once daily, as outlined in official prescribing documents. The tablets must be consumed with food to optimize absorption. Pediatric dosing for children two years of age and older is weight-based, typically 3.3 to 6.6 mg/kg once daily. No specific dosage adjustments are stated for patients with renal or hepatic impairment.

Topical regimens are generally once daily, though certain conditions or formulations may require twice daily application. The duration of treatment is fixed by the labeling: systemic use often requires approximately 6 months of administration, while topical courses typically range from 2 to 6 weeks. A key procedural step for the shampoo is the requirement for a 5-minute contact time before rinsing. Regarding schedule management, a missed dose should not be compensated for by taking a double dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ketocare

Evidence for Use in Seborrheic Dermatitis

Research explored the use of Ketocare topical formulations in adults and adolescents with seborrheic dermatitis. Research primarily involved short-term Randomized Controlled Trials (RCTs) and Systematic Reviews that summarized the findings from these individual trials. These studies generally included research exploring short-term symptom changes and measured outcomes linked to inflammatory or irritative states, such as scaling, redness, and itching, using clinical assessment tools. The evidence for topical formulations in this indication is based on studies where the design was reviewed for consistency, reflecting the quantity of available data across trials using similar endpoints.

Evidence for Use in Tinea Infections (Ringworm, Athlete's Foot, Jock Itch)

The research for the topical compound in Tinea infections (Tinea Pedis, Tinea Cruris, and Tinea Corporis) comes mainly from short- to intermediate-term RCTs. These studies compared the compound to placebo or sometimes to other antifungal agents. Researchers primarily measured two categories of outcomes: outcomes related to fungal status and patient-reported outcomes describing perceived discomfort. Research documented changes measured during the study period for both the fungal status and clinical outcomes reflecting daily functioning or activity level.

Evidence for Use in Serious Systemic Fungal Diseases

The oral tablet formulation was studied in research contexts involving certain endemic systemic fungal diseases, such as Blastomycosis and Histoplasmosis. The research for the oral tablet in systemic diseases relies on older clinical trials, open-label studies, and case series conducted primarily before the widespread availability of newer antifungal options. Early studies described patterns of changes in clinical status and fungal status following the observation period in specific, severe systemic fungal infections.

Research Gaps and Areas of Uncertainty

This synthesis highlights several important limitations across the entire research portfolio. Comparative evidence is lacking in modern trials against all currently available alternative treatments. For many indications, the follow-up durations were limited, meaning that long-term effects are not fully established, especially regarding continuous use or recurrence patterns. The sample sizes were modest in the older studies, particularly those involving the oral tablet for systemic diseases. This means that subgroup findings are uncertain, and results apply only to the populations studied under the specific conditions of the research.

Frequently Asked Questions (FAQ)

Common questions about Ketocare (FAQ)

Q: Do any common foods or drinks affect how Ketocare works?

Official prescribing information states that the oral tablet formulation is required to be taken with food to ensure the medicine is properly absorbed by the body. Furthermore, the consumption of alcohol is contraindicated, meaning its use is not permitted, because doing so may significantly increase the risk of severe adverse reactions.

Q: Can Ketocare be taken by people who are sensitive to certain ingredients?

Regulatory documents indicate that the topical cream formulation is not intended for use by individuals who have a known hypersensitivity to the active ingredient or any of the product's excipient (inactive) ingredients. If you have known allergies, review of official product information with a healthcare professional is consistent with patient safety guidance.

Q: Are there any long-term expected effects of using Ketocare for an extended period?

Research on the topical forms includes a 12-month study that documented the maintenance of effectiveness and a generally well-documented safety profile over that period. For the oral tablets, however, regulatory safety communications note that serious liver effects have been reported with both short and long treatment durations, which is consistent with restrictions placed on oral use.

Q: Does Ketocare have a high potential for interacting with over-the-counter supplements?

Official patient counseling advises that individuals should inform their healthcare provider about all over-the-counter products they are using, which includes vitamins and herbs. This recommendation is based on the potential for interactions that could affect how the medicine works or increase the risk of side effects.

Q: Is the effect of Ketocare temporary, or is it expected to be maintained over time?

The required duration of treatment is fixed by the official labeling (for example, systemic use for up to six months). Official research documents note that follow-up in older studies was limited, meaning that long-term recurrence patterns—the chance of the infection coming back—are not fully established after treatment ends.

Q: What does the research say about Ketocare's effectiveness in real-world use?

The evidence base is founded on studies like Randomized Controlled Trials and older clinical trials. These studies primarily measured outcomes that are visible or observable, such as clinical changes in scaling, redness, and itching, as well as laboratory measures of fungal status.

Q: Do people typically need to adjust their diet while taking Ketocare?

The main requirements related to diet are that the oral tablet is required to be consumed with food to achieve optimal absorption into the body. Separately, official documentation indicates that consuming alcohol is strictly contraindicated during the course of treatment.

Q: Does Ketocare interact with common pain relievers like ibuprofen or acetaminophen?

Caution is described in regulatory documents due to a potential for an increased risk of liver injury when Ketocare is used concurrently with certain common pain relievers that can also affect the liver.

Q: How can I tell if Ketocare is working for me?

In clinical trials, researchers assessed effectiveness by documenting changes in patient-reported outcomes describing perceived discomfort. They also measured visible signs, such as a reduction in scaling, redness, and itching.

Q: Does the time of day I take Ketocare matter?

Official labeling notes the prescription is typically once daily and taken at the same time each day to maintain a consistent level of the medicine in the body. Additionally, official instructions state that any stomach acid-reducing medicines should be taken at least 1-2 hours apart from the tablet dose.

Q: How do medical professionals monitor a patient's response to Ketocare?

For the oral tablets, regulatory guidelines recommend professional monitoring due to the risk of serious adverse effects. This monitoring includes specific liver function tests that are typically conducted prior to starting treatment and at regular intervals during the course of therapy.

Q: Are there any ethnic or racial groups for whom Ketocare works differently?

Research documents note that the sample sizes in older studies were modest. This is specified as a limitation meaning that subgroup findings, which includes any differences related to demographic factors, are uncertain.

Q: Can the effectiveness of Ketocare be affected by my weight?

Official prescribing information establishes a link between weight and dose for certain patients. Specifically, the dosage for children two years of age and older is calculated based on their body weight (mg/kg).

Q: What are the signs of a serious, but rare, side effect from Ketocare?

Official patient labeling describes signs of serious liver or heart issues. Regulatory documents instruct patients to seek immediate professional medical attention if these signs appear, including yellowing of the skin or eyes (jaundice), dark urine, extreme tiredness, or fainting/loss of consciousness.

Q: Is it normal to feel tired when first starting Ketocare?

Tiredness or weakness are listed in official documents as symptoms that may be associated with serious adverse effects. Additionally, extreme tiredness, or fatigue, is associated with potential liver injury and requires immediate medical attention.

Q: Is Ketocare considered a new drug, or has it been available for a long time?

The medication is not considered a first-line treatment for most indications and has been subject to multiple regulatory safety warnings and use restrictions due to its long history of documented severe adverse effects since its introduction.

Q: Can older adults generally use Ketocare?

Regulatory information notes that older adults may exhibit increased sensitivity to the effects or adverse reactions of the medication. For this population, regulatory information notes that additional monitoring or risk assessment may be required.

Q: Are there any specific laboratory tests that might be required while taking Ketocare?

For the oral tablets, regulatory guidelines recommend specific liver function tests (such as ALT and AST) that are performed prior to starting treatment and at regular intervals during the course of therapy.

Q: Does Ketocare affect sleep patterns?

The official documentation lists difficulty falling asleep or staying asleep (insomnia) as a potential side effect of the oral tablet formulation.

Q: Can Ketocare affect my ability to drive or operate machinery?

Official product information reports that side effects such as dizziness or somnolence (drowsiness) have occurred during treatment. Official product information advises that activities requiring mental alertness, such as driving or operating machinery, should be avoided if these symptoms occur.

Q: Is it common for people to gain or lose weight while taking Ketocare?

Regulatory patient labeling notes that unexplained weight loss is listed as a symptom that can be associated with serious adverse effects, such as potential liver injury. Regulatory patient labeling instructs patients to seek immediate medical attention if this symptom occurs.

Q: Is Ketocare available as a generic medicine?

The active ingredient, ketoconazole, is a well-established compound and is available in the form of generic medicines in many regions worldwide.

How should Ketocare be stored and disposed of?

Storage and Disposal Conditions for Ketoconazole

The official requirements for storing and disposing of Ketoconazole are based on maintaining the product's stability and safety, as documented in regulatory labeling.

Storage and Handling

Ketoconazole tablets and cream must be stored at Controlled Room Temperature (20 to 25 C / 68 to 77 F). The tablet formulation requires protection from light and moisture, and the shampoo must also be protected from light. The foam container must not be exposed to temperatures above 120 F (49 C), nor should it be punctured or incinerated due to flammability concerns. All formulations must be stored out of the reach of children.

Disposal

Unused or expired product should be disposed of according to local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Ketocare found in:

A-Z Index: